| Literature DB >> 24027760 |
Himanshu K Solanki1, Dipak D Pawar, Dushyant A Shah, Vipul D Prajapati, Girish K Jani, Akil M Mulla, Prachi M Thakar.
Abstract
The administration of probiotic bacteria for health benefit has rapidly expanded in recent years, with a global market worth $32.6 billion predicted by 2014. The oral administration of most of the probiotics results in the lack of ability to survive in a high proportion of the harsh conditions of acidity and bile concentration commonly encountered in the gastrointestinal tract of humans. Providing probiotic living cells with a physical barrier against adverse environmental conditions is therefore an approach currently receiving considerable interest. Probiotic encapsulation technology has the potential to protect microorganisms and to deliver them into the gut. However, there are still many challenges to overcome with respect to the microencapsulation process and the conditions prevailing in the gut. This review focuses mainly on the methodological approach of probiotic encapsulation including biomaterials selection and choice of appropriate technology in detailed manner.Entities:
Mesh:
Year: 2013 PMID: 24027760 PMCID: PMC3763591 DOI: 10.1155/2013/620719
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Clinical studies of appropriate probiotic strains which have convincingly demonstrated their therapeutic effect.
| Most appropriate probiotic strain(s) | Therapeutic application | References |
|---|---|---|
|
| Hypercholesterolemia and cardiovascular disease | [ |
|
| Prevention of atopy | [ |
|
| Eczema | [ |
|
| Food allergies | [ |
|
| Lowered immunity | [ |
|
| Antibiotic use (during and after) | [ |
|
| Nonsteroidal anti-inflammatory Drug | [ |
|
| Intestinal hyperpermeability | [ |
|
| Gastroenteritis | [ |
|
| Giardia infection | [ |
|
| Intestinal dysbiosis | [ |
|
| Lactose intolerance | [ |
|
| Peptic ulcer disease | [ |
|
| Irritable bowel syndrome | [ |
|
| Radiation-induced diarrhoea | [ |
|
| Traveller's diarrhoea | [ |
|
| Crohn's disease | [ |
|
| Ulcerative colitis | [ |
|
| Prevention of colon cancer | [ |
|
| Urinary tract infection | [ |
|
| Vaginal candidiasis (thrush) | [ |
Figure 1Schematic representation of encapsulation systems: (a) reservoir type, (b) matrix type, and (c) coated matrix type.
Figure 2Various forms of microcapsule used in the food industry [19].
Supported report provides evidence that encapsulation of probiotics results in increased viability.
| Sr. no. | Supported report provides evidence that encapsulation of probiotics results in increased viability | References |
|---|---|---|
| 1 | It has been investigated that when yoghurt isolates of | [ |
| 2 | The use of calcium-induced alginate starch coating has also improved the survivability of encapsulated cells of | [ |
| 3 | Whey protein-based microcapsules can improve the cell survival of probiotic bacteria under extreme conditions | [ |
| 4 | A combination of gellan-alginate was used to encapsulate | [ |
| 5 | Encapsulated cells also showed approximately 104 times increase in viability during exposure to acidic and bile salt conditions | [ |
| 6 | It was found that cells microencapsulated in alginate, carrageenan, and xanthan gum survived better than free cells following 2 h incubation in acidic condition (pH 2) | [ |
| 7 | It was found that cells encapsulated by extrusion using alginate and alginate with starch offered greater protection to cells in simulated gastric juice | [ |
| 8 | Chitosan coating of microbeads resulted in a significant increase in survival time of | [ |
Relative pH and transit time at various locations within GIT.
| Region | pH | Transit time |
|---|---|---|
| Oesophagus | ~7.0 | 10–14 seconds |
| Stomach | 1–2.5 (up to 5 fed) | Half emptying: ~80.5 mins |
| Proximal small intestine | 6.15–7.35 | 3.2 ± 1.6 hrs (combined) |
| Distal small intestine | 6.80–7.88 | |
| Ascending colon | 5.26–6.72 | Highly variable, dependent on bowel evacuation |
| Descending colon | 5.20–7.02 |
Figure 3Probiotic encapsulation technologies: size range provided by each technique.
Figure 4Extrusion technologies: simple needle droplet generator that usually is air driven (a) and pinning disk (b). The probiotic cells are added to the hydrocolloid solution and dripped through a syringe needle or a nozzle spray machine in the form of droplets which are allowed to free fall into a hardening solution such as calcium chloride.
Advantage and disadvantages of extrusion technique.
| Advantages | Disadvantages |
|---|---|
| (i) Simple and cheap method that uses a gentle operation | (i) Difficult to use for large scale production due to slow formation of microbeads |
Different probiotic strain, biomaterial, and size of microcapsule encapsulated by extrusion technique.
| Probiotic strain | Material | Size of capsule | Reference |
|---|---|---|---|
|
| 1.875% alginate | 2.5 mm | [ |
|
| 1.875% alginate | 2.6 mm | [ |
|
| 1% alginate | — | [ |
|
| 2% alginate + 0.4% chitosan | 2 mm | [ |
|
| 2% Alginate + 10% skim milk | 2 mm | [ |
|
| 1.5% alginate | — | [ |
|
| 2% alginate | — | [ |
|
| 2% alginate | — | [ |
|
| 1.8% alginate | [ | |
|
| 0.6% alginate + starch | 5 mm | [ |
|
| 0.75% gellan gum + 1% xanthan gum | 3 mm | [ |
|
| 1% xanthan gum + 0.5% gellan gum | — | [ |
|
| 1% alginate, poly-L-lysine | 2 mm | [ |
|
| 1.5% alginate + 0.1% poly-L-lysine and 0.1% alginate | 619 | [ |
|
| 1.8% alginate | 330–450 | [ |
|
| 2% alginate | 1.62 mm | [ |
|
| 2% alginate + 0.17% alginate | 1.89 mm | [ |
|
| 1.8% alginate + 0.4% chitosan | 356 | [ |
|
| 2% alginate + 2% corn starch | — | [ |
|
| 2% alginate + 0.05% poly-L-lysine | 1.89 mm | [ |
|
| 2% alginate, 1% gellan, 0.86% peptides, 0.2% FOS | — | [ |
|
| 3% alginate, 1% peptides, 3% FOS | — | [ |
|
| 2–4% alginate | 1.03–2.62 mm | [ |
|
| 3% alginate | — | [ |
|
| 1.75% | — | [ |
|
| 1.8% alginate + 1% Hi-Maize starch | — | [ |
|
| 3% | — | [ |
Different probiotic strain, biomaterial, and size of microcapsule encapsulated by emulsion technique.
| Probiotic strain | Material | Size of microcapsule | Reference |
|---|---|---|---|
|
| 3% | 0.5–2 mm | [ |
|
| 10% cellulose acetate phthalate | — | [ |
|
| 3% alginate | — | [ |
|
| 3% | 1-2 mm | [ |
|
| Chitosan (4%) | 150 | [ |
|
| 3.6% alginate | 30 | [ |
|
| 3% alginate | 25–35 | [ |
|
| 24% gelatin | 271–168 | [ |
|
| 2% alginate | 50 | [ |
|
| 3% alginate | — | [ |
|
| 2–4% alginate | — | [ |
|
| 2% alginate, 5% glycerol, 0.26% xanthan gum + 0.8% chitosan | 40–80 | [ |
|
| 2% alginate + 2% corn starch | — | [ |
|
| 2% alginate + 2% Hi-Maize starch | 0.5–1 mm | [ |
|
| 1.75% | — | [ |
|
| Milk fat + 10% whey protein isolate | 3–80 | [ |
|
| 1% xanthan + 0.5% gellan | [ | |
|
| 13% gelatin, 1.25 mM genipin + 1% alginate | 49–53 | [ |
Figure 5Schematic presentation of emulsification procedure: a small volume of the cell polymer suspension (i.e., the discontinuous phase) is added to a large volume of vegetable oil (i.e., the continuous phase). The mixture is then homogenized to form a water-in-oil emulsion. Once the water-in-oil emulsion is formed, the water-soluble polymer must be insolubilized to form tiny gel particles within the oil phase.
Figure 6Schematic presentation of the microencapsulation of probiotic cells by means of rennet-gelation of milk proteins: The principle of the technique is based on using dairy proteins which have been put in contact with rennet at low temperature. This allows keeping a liquid system where κ-casein is cleaved by the enzyme. After that, dairy proteins have been emulsified in a cold oil to form water in oil emulsion. Thermal induction of enzymatic coagulation allows proteins flocculation and provides microparticles where probiotics are dispersed in coagulated dairy proteins.
Figure 7Schematic presentation of the spray-drying procedure: The solution is pressured and then atomized to form a “mist” into the drying chamber. The hot gas (air or nitrogen) is blown into the drying chamber too. This hot gas allows the evaporation of the solvent. The capsules are then transported to a cyclone separator for recovery.
Advantage and disadvantages of spray drying techniques.
| Advantages | Disadvantages |
|---|---|
| The advantages of the spray drying process are ease of scaling up, low operational cost, continuous operation, and adaptability to most common industrial equipment | (i) However, spray drying may not be suitable particularly for probiotic bacteria due to requirement of high temperature drying [ |
Different probiotic strain, biomaterial, inlet/outlet temperature, and size of microcapsule encapsulated by spray drying techniques.
| Probiotic strain | Material | Inlet/outlet temperature | Size of capsule | Reference |
|---|---|---|---|---|
|
| 10% gelatin, gum arabic, | 100°C/50°C | 10–20 | [ |
|
| 20% skim milk | 175°C/68°C | — | [ |
|
| 20% skim milk + Raftilose or Polydextrose | —/80°C | [ | |
|
| 10% whey protein isolate | 160°C/80°C | 5–80 | [ |
|
| 10% waxy maize starch | 100°C/45°C | 5 | [ |
|
| 30% maltodextrin + 20% gum arabic | 100°C/50°C | 10 | [ |
|
| Cellulose acetate phthalate | 130°C/75°C | 22 | [ |
|
| Gum acacia (gum arabic) | 170°C/95–105°C | 5–15 | [ |
Advantage and disadvantages of fluidized bed drying.
| Advantages | Disadvantages |
|---|---|
| The advantages of this process are total control over the temperature, lower comparable cost | Disadvantage being relatively longer duration (up to 2 hours) [ |
Advantages and Disadvantages of spray freeze drying.
| Advantages | Disadvantages |
|---|---|
| The advantages are controlled size, large specific surface area than spray dried capsule | (i) Disadvantages are required high energy, long time, expensive than spray drying [ |
Figure 8Schematic presentation of the spray coating technology.
Advantages and disadvantages of coacervation technique.
| Advantages | Disadvantages |
|---|---|
| (i) The advantages are high payload (99%) and controls the release of core material [ | (i) The disadvantages are high cost of the particle isolation procedure and complexity of technique |
| (ii) The process can be carried out at room temperature making it particularly suitable for heat sensitive probiotic bacteria [ | (ii) But it was suggested that the optimization of the last step and use of spray dryer instead of fluidized or freeze dryer can reduce the overall cost [ |
Advantages and disadvantages of cocrystallization.
| Advantages | Disadvantages |
|---|---|
| The advantages are economical with high payload (90%). It is utilized in the confectionery and pharmaceutical industries | Disadvantages are higher control rate of nucleation, crystallization, and thermal balance during operation [ |
Advantages and disadvantages of alginate system.
| Advantages | Disadvantages |
|---|---|
| (i) The advantages are easy formation of gel matrices around bacterial cells, being nontoxic and cheap; mild process conditions are needed for their performance, easily prepared and performed and properly resolved in the intestine and release entrapped cell [ | (i) Disadvantages are susceptible to acidic environments, crackling and loss of mechanical stability in lactic acid [ |